Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAir China Regulatory News (AIRC)

Share Price Information for Air China (AIRC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.44523
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 43.44523
AIRC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Profit Warning

1 Feb 2021 07:00

RNS Number : 5051N
Air China Ld
01 February 2021
 

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

 

 

中國國際航空股份有限公司

AIR CHINA LIMITED

(a joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 00753)

 

Profit Warning

 

This announcement is made by Air China Limited (the "Company") pursuant to Rule 13.09 and Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the laws of Hong Kong).

 

I. ESTIMATED RESULTS FOR THE PERIOD

 

(I) Results Estimation Period

 

1 January 2020 to 31 December 2020.

 

(II) Estimated Results

 

1. According to the preliminary estimation of the finance department of the Company, the Company recorded losses in the year 2020. It is expected that the net loss attributable to equity holders of the Company would be approximately RMB13.5 billion to RMB15.5 billion, and the net loss attributable to equity holders of the Company after deducting non-recurring profit or loss would be approximately RMB13.8 billion to RMB15.9 billion.

 

2. The estimated results have not been audited by certified accountants.

 

II. RESULTS FOR THE CORRESPONDING PERIOD IN 2019

 

1. Net profit attributable to equity holders of the Company: RMB6,409 million.

Net profit attributable to equity holders of the Company after deducting non-recurring

profit or loss: RMB6,174 million.

 

2. Earnings per share: RMB0.47.

III. MAJOR REASONS FOR THE ESTIMATED LOSS FOR THE PERIOD

 

In 2020, the COVID-19 pandemic (the "Pandemic") caused a huge impact on the global civil aviation industry. The market demand for civil aviation passenger flights in China shrank with inverted input-output structure, and the passenger capacity on international airlines decreased to an extremely low level. The operation of the Company experienced unprecedented difficulties and challenges with a substantial decrease in overall revenue. Since the outbreak of the Pandemic, substantial, extensive and frequent flight adjustments as well as quarantine and pandemic prevention of the flight crew members have led to an increase in cost of the Company to a certain extent. Air transportation enterprises invested by the Company also recorded significant losses.

 

Amidst the Pandemic, the Company took a holistic approach in battling for pandemic prevention and control, safety production and operation performance, striving to minimize the impacts of the Pandemic. The Company despatched the pandemic control materials and medical teams promptly as well as facilitated the resumption of work and production to demonstrate the responsibility of an aviation enterprise. The Company insisted on the safety operation and vigorously strengthened safety risk management and control so as to ensure safe and stable operation. The Company also improved situation analysis as well as stepping up efforts in quality and efficiency improvement. By strictly implementing cost control measures, the Company strived to achieve operational performance target.

 

In the first half of the year, net loss attributable to equity holders of the Company amounted to RMB9,441 million. In the second half of the year, the Company closely seized market opportunities and continued to strengthen yield management and cost control and therefore the loss gradually narrowed down. It is expected that net loss for the year attributable to equity holders of the Company would be approximately RMB13.5 billion to RMB15.5 billion.

 

IV. RISK ALERT

 

There are no uncertainties which will affect the accuracy of these estimated results of the Company.

 

V. OTHER INFORMATION

 

The above estimated results are only a preliminary estimation, and the specific and accurate financial figures will be disclosed in the audited annual report of 2020 to be formally published by the Company. Investors are reminded to pay attention to the investment risks.

 

Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company.

 

By order of the Board

Air China Limited

Zhou Feng

Company Secretary

Beijing, the PRC, 29 January 2021

 

As at the date of this announcement, the directors of the Company are Mr. Song Zhiyong, Mr. Feng Gang, Mr. Patrick Healy, Mr. Xue Yasong, Mr. Wang Xiaokang*, Mr. Duan Hongyi*, Mr. Stanley Hui Hon-chung* and Mr. Li Dajin*.

 

* Independent non-executive director of the Company

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRGXGDDUSGDGBB
Date   Source Headline
15th Jul 20147:00 amRNSFormal Notice-Profit Warning
11th Jul 20147:00 amRNSFormal Notice-Notice of EGM
11th Jul 20147:00 amRNSFormal Notice-List of Directors
11th Jul 20147:00 amRNSFormal Notice-Change in Directors
8th Jul 20147:00 amRNSFormal Notice - Dividend or Distribution
27th Jun 20147:00 amRNSFormal Notice - Capital Injection
23rd May 20147:00 amRNSList of Directors and their Role
23rd May 20147:00 amRNSResults of 2013 AGM and Appointment of Directors
30th Apr 20147:01 amRNSFormal Notice - First Quarterly Report 2014
22nd Apr 20147:01 amRNSFormal Notice - Profit Warning
17th Apr 20147:00 amRNSFormal Notice - Annual Report
16th Apr 20147:00 amRNSFormal Notice - Date of Board Meeting
3rd Apr 20149:32 amRNSFormal Notice - Notice of Annual General Meeting
26th Mar 20147:00 amRNSFormal Notice - 2013 Annual Results
17th Mar 20147:00 amRNSFormal Notice - List of Directors and their Role
13th Mar 20147:00 amRNSFormal Notice - Date of Board Meeting
24th Feb 20147:00 amRNSFormal Notice-Change in Directors
30th Jan 20147:00 amRNSFormal Notice - Change in Chief Executive
28th Jan 20149:00 amRNSFormal Notice - List of Directors and their Role
28th Jan 20147:00 amRNSFormal Notice - Change in Directors
27th Jan 20147:00 amRNSFormal Notice - Resignation of Director
30th Dec 20139:00 amRNSOVERSEAS REGULATORY ANNOUNCEMENT
24th Dec 20137:00 amRNSANNOUNCEMENT ON INCREASE IN SHAREHOLDINGS
30th Oct 20137:00 amRNSAnnouncements and Notices - List of Directors
30th Oct 20137:00 amRNSTHIRD QUARTERLY REPORT 2013
30th Oct 20137:00 amRNSAnnouncements and Notices - Results of EGM
16th Oct 20137:00 amRNSAnnouncements and Notices - Date of Board Meeting
15th Oct 20137:21 amRNSCONTINUING CONNECTED TRANSACTIONS & NOTICE OF EGM
15th Oct 20137:00 amRNSSUPPLEMENTAL NOTICE OF EGM
15th Oct 20137:00 amRNSREVISED FORM OF PROXY FOR EGM
15th Oct 20137:00 amRNSAnnouncements and Notices - Change of Supervisors
27th Sep 20137:00 amRNSAnnouncements - Continuing Connected Transaction
27th Sep 20137:00 amRNSCONTINUING CONNECTED TRANSACTIONS
10th Sep 20137:16 amRNSNotice of EGM/Closure of Books/Other
10th Sep 20137:00 amRNSFinancial Statements - Interim Report
28th Aug 20137:00 amRNSINTERIM RESULTS/PROPOSED APPOINTMENT/OTHER
16th Aug 20137:00 amRNSDATE OF BOARD MEETING
27th Jun 20138:47 amRNSMajor Transactions Purchase of Aircraft
7th Jun 20137:00 amRNSSECOND GRANT OF STOCK APPRECIATION RIGHTS
28th May 20137:00 amRNSMAJOR TRANSACTION - PURCHASE OF AIRCRAFT
24th May 20137:00 amRNSPOLL RESULTS OF 2012 AGM AND PAYMENT OF DIVIDEND
23rd May 20137:00 amRNSARTICLES OF ASSOCIATION
23rd May 20137:00 amRNSAMENDMENTS TO THE ARTICLES OF ASSOCIATION
8th May 20137:00 amRNSREVISED FORM OF PROXY FOR ANNUAL GENERAL MEETING
8th May 20137:00 amRNSSUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
29th Apr 20137:00 amRNSFURTHER DELAY IN DESPATCH OF CIRCULAR
26th Apr 20137:00 amRNSANNUAL REPORT 2012
26th Apr 20137:00 amRNSFIRST QUARTERLY REPORT 2013
16th Apr 20138:00 amRNSDATE OF BOARD MEETING
3rd Apr 20138:59 amRNSCIRCULARS - [OTHER/GENERAL MANDATE]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.